背景实质强化对不同高危人群筛查乳腺MRI中癌症风险的影响
本研究回顾了2011至2014年间4686次筛查乳腺MRI检查(2446名女性),评估背景实质强化(BPE)在不同高危适应症人群中对乳腺癌风险的影响。多变量分析显示,仅BPE和筛查适应症是癌症诊断的独立预测因子;中重度BPE组较小轻度组的癌症风险比为2.1(95%CI 1.1-4.0)。
要点
- 中重度BPE较小轻度BPE的癌症风险比为2.1(95%CI 1.1-4.0),BPE是独立预测因子。
- 筛查适应症也是癌症诊断的独立预测因子(p<0.01)。
- BPE评估应纳入高危女性筛查乳腺MRI的报告中,作为风险分层参考。
核心结论
- 在接受筛查MRI的不同高危适应症女性中,BPE水平升高是乳腺癌的独立预测因子。
研究设计与样本
- 回顾性分析2011至2014年连续筛查乳腺MRI检查,共4686次检查(2446名女性);采用多变量逻辑回归(广义估计方程)评估年龄、BPE(前瞻性临床评估:轻微/轻度 vs 中度/明显)、乳腺X线密度和筛查适应症与癌症风险的关联;癌症定义为筛查MRI后12个月内组织学诊断的浸润性或原位癌。
诊断标准与关键数值
- BPE分组:轻微或轻度3975/4686(85%),中度或明显711/4686(15%)。
- 筛查适应症分组:BRCA携带者或胸部放疗史548/4686(12%),乳腺癌个人史2541/4686(54%),高危病变362/4686(8%),乳腺癌家族史1235/4686(26%)。
- 中重度BPE组较小轻度BPE组的癌症风险OR为2.1(95%CI 1.1-4.0),校正年龄、乳腺密度和筛查适应症后。
临床应用与阅片要点
- 在筛查乳腺MRI报告中,应评估并记录BPE水平(轻微/轻度 vs 中度/明显),因其与癌症风险独立相关。
- 对于中重度BPE的高危女性,可结合筛查适应症综合评估癌症风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to evaluate the effect of background parenchymal enhancement (BPE) on breast cancer risk across different high-risk patient populations undergoing screening breast MRI.
MATERIALS AND METHODS: Consecutive screening breast MRI examinations performed between 2011 and 2014 were reviewed. Multivariate logistic regression using generalized estimating equations was used to assess the association of the following variables with cancer risk: age, qualitative BPE prospective clinical assessment (minimal or mild vs moderate or marked), mammographic breast density (dense vs not dense), and screening indication (prioritized in the following order: BRCA carrier or history of thoracic radiation, breast cancer personal history, high-risk lesion, and breast cancer family history). Cancer diagnosis was defined as a tissue diagnosis of invasive or in situ carcinoma within 12 months of the screening MRI.
RESULTS: The study cohort included 4686 screening MRI examinations performed in 2446 women, grouped by BPE as minimal or mild (3975/4686; 85%) versus moderate or marked (711/4686; 15%) and by screening indication as BRCA carrier or history of thoracic radiation (548/4686; 12%), breast cancer personal history (2541/4686; 54%), high-risk lesion (362/4686; 8%), and breast cancer family history (1235/4686; 26%). After adjustment for confounding variables, only BPE and screening indication were independent predictors of cancer diagnosis (p = 0.02 and p < 0.01, respectively). The odds ratio for developing cancer in the moderate or marked BPE group compared with the minimal or mild group was 2.1 (95% CI, 1.1-4.0), after adjusting for age, breast density, and screening indication.
CONCLUSION: Increased BPE level is an independent predictor of breast cancer in women undergoing screening MRI for different high-risk indications.
引用
- Sippo DA, Rutledge GM, Burk KS, et al. Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI. AJR Am J Roentgenol. 2019. PMID: 30888867. doi:10.2214/AJR.18.20566
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。